IP Verse

Biodel competitive analysis

Latest publications and patents of Biodel New

Explore the latest publications and patents granted to Biodel, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Biodel

EP2403520
Apr 25, 2018Insulin Formulations For Rapid UptakeRevoked
EP2293751
Jan 10, 2018Multidirectional Mucosal Delivery Devices And Methods Of UseNo Opposition Filed Within Time Limit

Latest patents of Biodel opposed by its competitors

Explore Biodel's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2403520
Apr 25, 2018Insulin Formulations For Rapid Uptake2

Latest PTAB cases involving Biodel

Discover the latest PTAB cases involving Biodel, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 29, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Biodel

IPR2015-00169Oct 28, 2014BIODELIVERY SCIENCESMONOSOL RXFinal Written Decision
IPR2015-00168Oct 28, 2014BIODELIVERY SCIENCESMONOSOL RXFinal Written Decision
IPR2015-00167Oct 28, 2014BIODELIVERY SCIENCESMONOSOL RXInstitution Denied
IPR2015-00165Oct 28, 2014BIODELIVERY SCIENCESMONOSOL RXTerminated-Settled
IPR2014-00998Jun 20, 2014BIODELIVERY SCIENCESRB PHARMACEUTICALSInstitution Denied
IPR2014-00794May 21, 2014BIODELIVERY SCIENCESMONOSOL RXInstitution Denied
IPR2014-00325Jan 15, 2014BIODELIVERY SCIENCESRB PHARMACEUTICALSFinal Written Decision
IPR2013-00316Jun 12, 2013BIODELIVERY SCIENCESMONOSOL RXInstitution Denied
IPR2013-00315Jun 12, 2013BIODELIVERY SCIENCESMONOSOL RXInstitution Denied

Peer Comparison New

IP litigation analysis comparing Biodel with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
BIODEL - 2 - - Non-Active
BOHMANN6 - - - Highly Aggressive
MAIKOWSKI & NINNEMANN PATENTANWALTE PARTNERSCHAFT MBB8 - - - Highly Aggressive